Page 124 - 《中国药房》2024年14期
P. 124

静脉用药复溶剂生成系统及溶媒配伍禁忌规则库的建立及应用
                                                                                                           Δ


                *
          黄 莺 ,李培芳,杜德才,方 明,刘 圣 [中国科学技术大学附属第一医院(安徽省立医院)药学部,合肥
                                                 #
          230001]

          中图分类号  R95      文献标志码  A      文章编号  1001-0408(2024)14-1786-04
          DOI  10.6039/j.issn.1001-0408.2024.14.20

          摘   要  目的  规范注射用无菌粉末复溶剂及静脉用药溶媒的使用,保障临床用药安全。 方法  我院审方药师团队通过制定需用
          灭菌注射用水溶解的药品目录和静脉用药溶媒配伍禁忌表,在医院信息系统中搭建静脉用药复溶剂生成系统及静脉用药溶媒配
          伍禁忌规则库。统计分析我院2023年1-4月(静脉用药溶媒配伍禁忌规则库实施前)和2023年5-8月(实施后)审核干预的不合
          理医嘱,比较实施前后我院溶媒选择不合理医嘱数量、拦截率及药师对溶媒选择不合理医嘱干预成功率的变化情况。结果  我院
          静脉用药溶媒配伍禁忌规则库实施前,共发现溶媒选择不合理医嘱5 229组,其中严重不合理医嘱有1 204组,拦截率为23.03%,
          审方药师对其的干预成功率为15.90%;实施后,共发现溶媒选择不合理医嘱3 258组,其中严重不合理医嘱有1 148组,拦截率为
          35.24%,药师对其的干预成功率为24.83%,均显著高于实施前(P<0.01或P<0.001)。结论  我院通过建立并应用静脉用药复溶
          剂生成系统及静脉用药溶媒配伍禁忌规则库,显著提高了对溶媒选择不合理医嘱的拦截率和药师干预成功率,有助于保障患者用
          药安全。
          关键词  注射用无菌粉末;复溶剂;溶媒;配伍禁忌

          Establishment and application of intravenous drug resolvent generation system and solvent incompatibility
          rules library
          HUANG Ying,LI Peifang,DU Decai,FANG Ming,LIU Sheng[Dept.  of  Pharmacy,  the  First Affiliated  Hospital
          of University of Science and Technology of China (Anhui Provincial Hospital), Hefei 230001, China]

          ABSTRACT    OBJECTIVE  To  standardize  the  use  of  sterile  powder  for  injection  redissolution  solvent  and  intravenous  drugs
          diluent  solvent,  and  ensure  the  safety  of  clinical  drug  use.  METHODS  The  intravenous  drug  resolvent  generation  system  and  the
          intravenous drug solvent incompatibility rules library were constructed and operated by prescription-checking pharmacist team in our
          hospital  by  formulating  a  list  of  intravenous  drugs  needed  to  be  dissolved  with  sterilized  water  for  injection  and  a  contraindication
          list  of  intravenous  solvent  compatibility. The  unreasonable  medical  orders  reviewed  and  intervened  in  our  hospital  from  January  to
          April 2023 (before the implementation of the intravenous drug solvent incompatibility rules library) and from May to August 2023
         (after the implementation) were analyzed statistically to compare the number of unreasonable solvent selection orders, interception
          rate,  and  the  success  rate  of  pharmacists’  interventions  for  unreasonable  solvent  selection  orders  before  and  after  the
          implementation.  RESULTS  Before  the  implementation  of  the  solvent  incompatibility  rules  library,  a  total  of  5  229  groups  of
          medical  orders  with  unreasonable  solvent  selection  in  our  hospital  were  identified,  among  which  there  were  1  204  groups  of
          seriously  unreasonable  medical  orders,  with  interception  rate  of  23.03%  and  the  success  rate  of  pharmacists’  intervention  of
          15.90%. After the implementation of the solvent incompatibility rules library, the total number of medical orders with unreasonable
          solvent  selection  was  3  258  groups,  among  which  there  were  1  148  groups  of  seriously  unreasonable  medical  orders,  with
          interception  rate  of  35.24%  and  success  rate  of  pharmacists’  intervention  of  24.83%,  being  significantly  higher  than  before
          implementation (P<0.01  or  P<0.001).  CONCLUSIONS  The  establishment  and  application  of  the  intravenous  drug  resolvent
          generation system and the solvent incompatibility rules library can significantly increase the interception rate of unreasonable solvent
          selection orders and the success rate of pharmacists’  interventions, and ensure the safety of clinical drug use.
          KEYWORDS     sterile powder for injection; redissolution solvent; solvent; incompatibility



              Δ 基金项目 安徽省教育厅高等学校省级质量工程项目(No.                       静脉用药物通过静脉注射或静脉滴注等方式直接
          2020jyxm2319)                                       进入血液循环,起效迅速,为临床预防、治疗和诊断疾病
             *第一作者 副主任药师,硕士。研究方向:医院药学、药理学、循
                                                              的常用剂型。为保证静脉用药物的稳定性,许多药物被
          证医学。E-mail:79485443@qq.com
                                                              制成注射用无菌粉末,也称“粉针”,临用时用适宜的复
              # 通信作者 主任中药师。研究方向:中药学。E-mail:lslcclhl@
          163.com                                             溶剂充分溶解,再用溶媒进一步稀释成一定浓度的成品


          · 1786 ·    China Pharmacy  2024 Vol. 35  No. 14                            中国药房  2024年第35卷第14期
   119   120   121   122   123   124   125   126   127   128   129